Breakthrough polymer-based therapy shows promise in reversing Huntington’s disease symptoms by preventing toxic protein clumps and enhancing neuronal survival.
Navigating the global epilepsy clinical trial landscape in 2024 – Pharmaceutical Technology
Credit: Shutterstock Epilepsy is a chronic neurological condition characterised by recurring seizures, involuntary movements affecting the body. Idiopathic generalised epilepsy is the most common form,